Similar articles for PMID: 31713583

Year	Number of Results
1994	2
1998	2
1999	3
2000	2
2002	3
2003	2
2004	3
2005	3
2006	1
2007	3
2008	2
2009	1
2010	1
2011	3
2012	2
2013	8
2014	13
2015	11
2016	13
2017	9
2018	9
2019	6
2020	6
2021	7
2022	4
2023	0

1

Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis.

Mueller S, Luderer M, Zhang D, Meulien D, Brach BS, Schou MB. Mueller S, et al. Alcohol Alcohol. 2020 Feb 7;55(1):63-70. doi: 10.1093/alcalc/agz078. Alcohol Alcohol. 2020. PMID: 31713583 Clinical Trial.

2

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group. Gual A, et al. Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3. Eur Neuropsychopharmacol. 2013. PMID: 23562264 Clinical Trial.

3

Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies.

van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K. van den Brink W, et al. Alcohol Alcohol. 2013 Sep-Oct;48(5):570-8. doi: 10.1093/alcalc/agt061. Epub 2013 Jul 19. Alcohol Alcohol. 2013. PMID: 23873853 Free PMC article. Clinical Trial.

4

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.

Mann K, Bladström A, Torup L, Gual A, van den Brink W. Mann K, et al. Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11. Biol Psychiatry. 2013. PMID: 23237314 Clinical Trial.

5

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study.

van den Brink W, Sørensen P, Torup L, Mann K, Gual A; SENSE Study Group. van den Brink W, et al. J Psychopharmacol. 2014 Aug;28(8):733-44. doi: 10.1177/0269881114527362. Epub 2014 Mar 26. J Psychopharmacol. 2014. PMID: 24671340 Clinical Trial.

6

Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence.

Higuchi S, Takahashi M, Murai Y, Tsuneyoshi K, Nakamura I, Meulien D, Miyata H. Higuchi S, et al. Psychiatry Clin Neurosci. 2020 Aug;74(8):431-438. doi: 10.1111/pcn.13017. Epub 2020 May 27. Psychiatry Clin Neurosci. 2020. PMID: 32359104 Free PMC article. Clinical Trial.

7

Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A. Barrio P, et al. Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4. Clin Drug Investig. 2018. PMID: 29080208 Clinical Trial.

8

Nalmefene. Alcohol dependence: no advance.

[No authors listed] [No authors listed] Prescrire Int. 2014 Jun;23(150):150-2. Prescrire Int. 2014. PMID: 25121147

9

Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.

Soyka M, Friede M, Schnitker J. Soyka M, et al. Pharmacopsychiatry. 2016 Mar;49(2):66-75. doi: 10.1055/s-0035-1565184. Epub 2016 Feb 4. Pharmacopsychiatry. 2016. PMID: 26845589

10

Nalmefene: a review of its use in the treatment of alcohol dependence.

Keating GM. Keating GM. CNS Drugs. 2013 Sep;27(9):761-72. doi: 10.1007/s40263-013-0101-y. CNS Drugs. 2013. PMID: 23949908 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed